These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33419264)

  • 21. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
    Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
    Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential compression devices for treatment of restless legs syndrome.
    Eliasson AH; Lettieri CJ
    Medicine (Baltimore); 2007 Nov; 86(6):317-323. PubMed ID: 18004176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sternberg working memory performance following treatment with pramipexole in patients with moderate-to-severe restless legs syndrome.
    Jung KY; Kim SM; Song JY; Lee BU; Lee C; Lee SK; Koo YS; Cho YW; Choi JW; Kim KH
    Sleep Med; 2015 Jun; 16(6):703-8. PubMed ID: 25934537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
    Kallweit U; Siccoli MM; Poryazova R; Werth E; Bassetti CL
    Eur Neurol; 2009; 62(3):176-9. PubMed ID: 19602890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioids for restless legs syndrome.
    de Oliveira CO; Carvalho LB; Carlos K; Conti C; de Oliveira MM; Prado LB; Prado GF
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD006941. PubMed ID: 27355187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
    Enomoto M; Inoue Y; Namba K; Munezawa T; Matsuura M
    Mov Disord; 2008 Apr; 23(6):811-6; quiz 926. PubMed ID: 18074382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
    Cuellar NG; Ratcliffe SJ
    Altern Ther Health Med; 2009; 15(2):22-8. PubMed ID: 19284179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive function in patients with idiopathic Restless Legs Syndrome before and after treatment with dopamine-agonist.
    Galbiati A; Marelli S; Giora E; Zucconi M; Oldani A; Ferini-Strambi L
    Int J Psychophysiol; 2015 Mar; 95(3):304-9. PubMed ID: 25514234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender differences in clinical, laboratory and polysomnographic features of restless legs syndrome.
    Holzknecht E; Hochleitner M; Wenning GK; Högl B; Stefani A
    J Sleep Res; 2020 Jun; 29(3):e12875. PubMed ID: 31162763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole body and local cryotherapy in restless legs syndrome: A randomized, single-blind, controlled parallel group pilot study.
    Happe S; Evers S; Thiedemann C; Bunten S; Siegert R
    J Neurol Sci; 2016 Nov; 370():7-12. PubMed ID: 27772790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.
    Nomura T; Inoue Y; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):39-44. PubMed ID: 16899256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptoms of attention-deficit/hyperactivity disorder in adults with restless legs syndrome.
    Wagner ML; Walters AS; Fisher BC
    Sleep; 2004 Dec; 27(8):1499-504. PubMed ID: 15683140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the Kohnen Restless Legs Syndrome-Quality of Life instrument.
    Kohnen R; Martinez-Martin P; Benes H; Trenkwalder C; Högl B; Dunkl E; Walters AS
    Sleep Med; 2016 Aug; 24():10-17. PubMed ID: 27810174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daytime symptoms of restless legs syndrome--clinical characteristics and rotigotine effectiveness.
    Takahashi M; Ikeda J; Tomida T; Hirata K; Hattori N; Inoue Y
    Sleep Med; 2015 Jul; 16(7):871-6. PubMed ID: 26002761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quality of life and associated characteristics of restless legs syndrome in the adult population of Burgos, Spain].
    Barroso-Perez MT; Cubo E; Cordero-Guevara J; Poza-Maure E; Checa-Diez L
    Rev Neurol; 2017 Sep; 65(6):257-262. PubMed ID: 28895999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower molecular weight intravenous iron dextran for restless legs syndrome.
    Cho YW; Allen RP; Earley CJ
    Sleep Med; 2013 Mar; 14(3):274-7. PubMed ID: 23333678
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.